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Among the first documented studies on
the chemistry of fungal natural products
were descriptions of quinoid pigments,
i.e., the L-tyrosine- and L-phenylalanine-
derived terphenylquinones atromentin
and polyporic acid, respectively. The isola-
tion of these compounds from mushroom
fruiting bodies (basidiomes) was pub-
lished around 1877 by Stahlschmidt and
Thörner. Ever since, organic chemists
embraced basidiomycetes as a prolific
source of bioactive compounds and
investigated these fungi with regard to
compound isolation, structure elucida-
tion, and synthesis (Gill and Steglich,
1987; Zhou and Liu, 2010; De Silva et al.,
2013 and previous reviews referenced
therein, Lorenzen and Anke, 1998; Richter
et al., in press). Mushrooms seem to be
particularly talented in producing unique
terpenoids, and the molecular background
behind the biosynthesis of some of those
compounds has only recently been elu-
cidated (Quin et al., 2014). Prominent
examples of basidiomycete metabolites
for lead structures in agrochemistry and
drug research are, among others, the
strobilurins, i.e., agriculturally used ß-
methoxyacrylate fungicides from cultures
of Mycena, Oudemansiella, Strobilurus,
Xerula and several other basidiomycete
genera (Sauter et al., 1999, Figure 1).
Other examples are the pleuromutilins, the
illudins, and the omphalotins (Figure 1).
The pleuromutilins from cultures of
species that are now placed in the gen-
era Clitopilus and Omphalina served
as scaffold for the development of the
semisynthetic antibacterial antibiotic reta-
pamulin (Kirst, 2013) which is clinically
used for topical treatment of infections
with Staphylococcus aureus. The illudins
from Lampteromyces and Omphalotus
species (Omphalotaceae) are sesquiter-
penes featuring an unusual cyclopropane
ring and are currently developed as anti-
cancer drugs (Tanasova and Sturla, 2012).
The omphalotins are cyclopeptides with
pronounced nematicidal activites against
root knot nematodes (Büchel et al., 1998),
which are also exclusively found in the
Omphalotaceae. Recently, the blazeispirols
fromAgaricus subrufescenswere discovered
as strong and selective agonists of the Liver
X receptor (LXR alpha). Concurrently, rel-
evant in vivo effects of blazeispirols in a
mouse model were observed which might
give rise to the development of a new anti-
hypercholesterolemic agent from cultures
of a medicinal mushroom (Grothe et al.,
2011).
The above examples illustrate that
basidiomycete secondary metabolomes
merit further exploration. Perhaps fortu-
nately for coming generations of Ph.D.
students, the realm of basidiomycete
metabolites is still underexplored, even
after decades of intensive research to iso-
late and structurally elucidate compounds.
This is also evident by the fact that toxic
principles of mushrooms which repeat-
edly led to poisonings were identified only
recently (Figure 1). Recent advances per-
tain to Trogia venenata fruiting bodies, in
which the toxic 2R-amino-5-hexynoic acid
and related compounds were found (Zhou
et al., 2012). Cycloprop-2-ene carboxylic
acid causing rhabdomyolysis was isolated
from Russula subnigricans, a toxic mush-
room native to East Asia (Matsuura et al.,
2009). Furthermore, saponaceolide tox-
ins with their unusual molecular skeleton
were discovered in Tricholoma terreum
(Yin et al., 2014).
For basidiomycetes, the genomic era
set in later than for ascomycetes, and
in numbers of genome projects the for-
mer are still lagging behind the latter.
Still, the available genomic data impacted
natural product research as it reveals
a stimulating disparity: the number of
natural product genes, best reflected by
the number of genes for polyketide syn-
thases and peptide synthetases exceeds the
number of known compounds by far—
even after decades of chemical research.
The “house eater” fungus Serpula lacry-
mans encodes 21 PKS and NRPS genes
(Eastwood et al., 2011), the average num-
ber of PKS genes per basidiomycete
genome is four, according to a survey of
35 mostly saprotrophic species (Lackner
et al., 2012).
The wealth of natural product biosyn-
thesis genes in a given species contrasts
the few compounds known from the same
species. This situation is reminiscent of
what was found for ascomycete genomes
years ago, e.g., for the genera Aspergillus,
Penicillium, Fusarium, and others (Keller
et al., 2005; Desjardins and Proctor, 2007;
Sanchez et al., 2012). However, the course
research has taken (and will be taking) to
make as much sense as possible out of
the genomic data is quite different with
basidiomycetes. This is due to a number
of reasons that contrast the situation with
ascomycetes.
(a) Basidiomycetes are mostly dikaryotic
and hence little suitable for reverse
genetics, although some species grow
as monokarya in vitro.
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FIGURE 1 | Chemical structures of pharmacologically active basidiomycete natural products.
(b) Basidiomycetes are little amenable,
if at all, to transformation and
genetic manipulation, as only a
very modest number of genetic
tools and procedures are in place.
Notable exceptions with regard
to producers of pharmacologi-
cally active metabolites pertain to
the honey mushroom Armillaria
mellea (Baumgartner et al., 2010)
which produces the melleolides, i.e.,
unusual sesquiterpene ester antibi-
otics (Bohnert et al., 2014). Also, a
transformation procedure was estab-
lished for the pleuromutilin producer
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Clitopilus passeckerianus (Kilaru et al.,
2009).
(c) The ecological preferences of numer-
ous basidiomycetes have so far
remained obscure and can only
now be established by using mod-
ern methods of molecular ecology.
For instance, some species that
were hitherto regarded as sapro-
trophs, such as Hygrocybe virginea,
are now suspected to possess hith-
erto unknown associations with
plants, illustrating in-depth stud-
ies on their ecology might in
future be rewarding (Tello et al.,
2014).
(d) Many basidiomycetes, in particular
the biotrophic pathogens, are diffi-
cult or virtually impossible to grow in
axenic culture. This applies e.g., to the
entire subdivision Pucciniomycotina,
(“rust fungi”) and to the obligate
mycorrhizal taxa, comprising impor-
tant families, such as the Russulaceae
and Cortinariaceae, from whose
basidiomes numerous unique sec-
ondary metabolites have already been
obtained. Even in some other “sapro-
trophic” genera, such as Pluteus, the
basidiospores do not readily germi-
nate, and stable cultures can hardly
be established from sterile mycelial
plugs taken out of the basidome tis-
sues using standard methodology.
Protocols to culture rust fungi or
mycorrhizal symbionts have been
elaborated by competent mycologists
several decades ago. We encourage
the community to also empha-
size teaching classical mycological
techniques, to educate the coming
generation of mycologists and pre-
vent these valuable methods from
slowly being forgotten. In fact, such
techniques could be useful to facil-
itate work on the genomics and
metabolomics of these organisms
since stable cultures could be used
for propagation of sufficient biomass
and a number of other interesting
tasks.
The typical approach to explore metabolic
pathways includes gene inactivation, com-
bined with chemical characterization of
the resulting phenotype. Whereas for
model species/genera such as Aspergillus
and other ascomycetes, numerous pro-
cedures and protocols were in place for
reverse genetics, to manipulate expres-
sion of silent natural product genes, and
to harness -omics technologies, this is
only modestly (if at all) the case for
basidiomycetes. Hence, the above rea-
sons add more complexity to research
which aims at functionally characteriz-
ing individual genes and basidiomycete
secondary metabolomes. Consequently,
despite chemically intriguing and unique
features of their natural products, and
also for the lack of robust biotechno-
logical expression systems, basidiomycetes
have not become the objects of choice.
As long as the respective genes, enzymes,
and mechanisms are present elsewhere,
e.g., in Aspergillus or Fusarium species,
or in streptomycetes, these will be pre-
ferred organisms. Projects including these
organisms will be sooner finished and
sooner published. On the other hand,
one new basidiomycete genome after the
other is currently released and sequence
data are made available at a much faster
pace than biochemists and natural prod-
uct chemists can keep up with. Hence,
an increasing amount of (natural prod-
uct gene) sequence data is produced and
because verification by wet-bench work
cannot keep pace the amount of hypo-
thetical andmisannotated natural produce
genes is ever-increasing.
Despite all these challenges there are
three encouraging reasons why basid-
iomycetes advance mycology and natural
product chemistry. Firstly, unique struc-
tures, e.g., the ones mentioned in the
introduction, deserve elucidation of the
biochemically andmechanistically intrigu-
ing basis behind their biogenesis. Secondly,
fungi as such are a widely unexplored
source for novel biotechnological prod-
ucts in general (cf. Rambold et al., 2013),
and this especially holds true for the
basidiomycetes. These two reasons alone
justify new genomes to be sequenced.
Finally, basidiomycetes are of outstand-
ing ecological significance and may be key
to answer the question as to why nat-
ural products exist. Due to their ability
to form mycorrhizae with conifers and
deciduous trees, they are key elements
of temperate and boreal climax vegeta-
tions. They efficiently degrade lignocellu-
lose which makes them indispensable to
keep the global carbon cycles going. The
basidiomycetes and the existing genomes
represent a good opportunity to follow a
different approach, but still contributing
substantially to natural product research:
with perhaps a dozen of carefully cho-
sen symbiotic, parasitic, and saprotrophic
species and a concerted effort of mycol-
ogists, chemists, ecologists, biochemists
and bioinformaticians we may come to a
more profound understanding why these
magnificent small molecules were evolved,
beyond the established examples that they
serve as defense agents and to compete
with other microbes in their ecological
niche.
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